CSL Limited (CSLLY)
(Delayed Data from OTC)
$92.92 USD
-0.84 (-0.90%)
Updated Nov 1, 2024 03:58 PM ET
4-Sell of 5 4
C Value B Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 36% (89 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.29 | 1.38 | 9.99 |
Current Quarter Estimate | NA | 1.62 | 63.00 |
Year Ago Quarter Estimate | NA | -4.98 | 52.25 |
Next Quarter Estimate | NA | 3.45 | 66.00 |
Next Year Estimate | 3.97 | 21.80 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 11.63 | 17.50 | 15.67 |
Next Year | 18.15 | 9.20 | 11.34 |
Last 5 Years | 7.30 | 4.00 | 8.10 |
Next 5 Years | 14.70 | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.23 |
Price/Book (MRQ) | 4.63 | 1.97 |
Price/Cash Flow (MRFY) | 23.36 | 14.45 |
Dividend Yield | 1.45% | 0.00% |
Net Profit Margin (TTM) | NA | -6.09% |
Return on Equity (TTM) | NA | -35.66% |
Debt to Equity (MRQ) | NA | 18.11 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.